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Developing Country Vaccine Industry represented by
Developing Country Vaccine Manufacturer Network has a
track record of manufacturing high quality vaccines.The timely
and consistently supplies by DCVMN has led to significant
progress in expanding the coverage of vaccine globally, result-
ing in the prevention of more than 2 million death annually.
The contributions of industry to polio eradication, meningi-
tis epidemic, pandemic influenza, MMR vaccination and DPT-
based combination vaccines have created a significant impact
on global health indicators [1]. Developing Country Vaccine
Industry is now taking steps individually, collectively, and
through alliances to develop newer vaccines and contribute
to improved global health through increased access, availabil-
ity, affordability, and adoption of vaccines in developing and
developed countries [2]. The industry is well positioned
today; however, doing this on sustainable basis has its own
challenges [1, 3]. The case study will provide an overview of
developing country industry contributions to global vaccine
supplies.
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